Wednesday, December 18, 2013

GlaxoSmithKline,
which makes Advair for asthma, Lovaza for high triglyceride levels and the
diabetes drug Avandia, is under pressure facing all drug companies for greater
transparency in payments to doctors, a provision of Obamacare

Scientific
American

By Charles Ornstein and ProPublica

In a major
departure from industry practice, GlaxoSmithKline, the sixth-largest global
drug maker, announced Tuesday that it will no longer hire doctors to promote
its drugs.

The company
also will stop tying compensation for sales representatives to the number of
prescriptions written for drugs they market. The changes will be made worldwide
over the next two years.